BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang HN, Zeng B, Zhang Y, Daskoulidou N, Fan H, Qu JM, Xu SZ. Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancer. PLoS One 2013;8:e67637. [PMID: 23840757 DOI: 10.1371/journal.pone.0067637] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Tran MT. Overview of Ca2+ signaling in lung cancer progression and metastatic lung cancer with bone metastasis. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2021.00045] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Faouzi M, Hague F, Geerts D, Ay AS, Potier-Cartereau M, Ahidouch A, Ouadid-Ahidouch H. Functional cooperation between KCa3.1 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis. Oncotarget 2016;7:36419-35. [PMID: 27183905 DOI: 10.18632/oncotarget.9261] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
3 Elzamzamy OM, Penner R, Hazlehurst LA. The Role of TRPC1 in Modulating Cancer Progression. Cells 2020;9:E388. [PMID: 32046188 DOI: 10.3390/cells9020388] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
4 Saldías MP, Maureira D, Orellana-Serradell O, Silva I, Lavanderos B, Cruz P, Torres C, Cáceres M, Cerda O. TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer. Front Oncol 2021;11:621614. [PMID: 34178620 DOI: 10.3389/fonc.2021.621614] [Reference Citation Analysis]
5 Oda K, Umemura M, Nakakaji R, Tanaka R, Sato I, Nagasako A, Oyamada C, Baljinnyam E, Katsumata M, Xie L, Narikawa M, Yamaguchi Y, Akimoto T, Ohtake M, Fujita T, Yokoyama U, Iwatsubo K, Aihara M, Ishikawa Y. Transient receptor potential cation 3 channel regulates melanoma proliferation and migration. J Physiol Sci 2017;67:497-505. [DOI: 10.1007/s12576-016-0480-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
6 Sobradillo D, Hernández-Morales M, Ubierna D, Moyer MP, Núñez L, Villalobos C. A reciprocal shift in transient receptor potential channel 1 (TRPC1) and stromal interaction molecule 2 (STIM2) contributes to Ca2+ remodeling and cancer hallmarks in colorectal carcinoma cells. J Biol Chem 2014;289:28765-82. [PMID: 25143380 DOI: 10.1074/jbc.M114.581678] [Cited by in Crossref: 66] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
7 Asghar MY, Törnquist K. Transient Receptor Potential Canonical (TRPC) Channels as Modulators of Migration and Invasion. Int J Mol Sci 2020;21:E1739. [PMID: 32138386 DOI: 10.3390/ijms21051739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang J, He Y, Yang G, Li N, Li M, Zhang M. Transient receptor potential canonical 1 channel mediates the mechanical stress‑induced epithelial‑mesenchymal transition of human bronchial epithelial (16HBE) cells. Int J Mol Med 2020;46:320-30. [PMID: 32319532 DOI: 10.3892/ijmm.2020.4568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Bulk E, Todesca LM, Schwab A. Ion Channels in Lung Cancer. Rev Physiol Biochem Pharmacol 2020. [PMID: 32772273 DOI: 10.1007/112_2020_29] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hirata N, Yamada S, Yanagida S, Ono A, Yasuhiko Y, Nishida M, Kanda Y. Lysophosphatidic Acid Promotes the Expansion of Cancer Stem Cells via TRPC3 Channels in Triple-Negative Breast Cancer. Int J Mol Sci 2022;23:1967. [PMID: 35216080 DOI: 10.3390/ijms23041967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Singh J, Hussain Y, Luqman S, Meena A. Targeting Ca2+ signalling through phytomolecules to combat cancer. Pharmacol Res 2019;146:104282. [PMID: 31129179 DOI: 10.1016/j.phrs.2019.104282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Tapia-Vieyra JV, Delgado-Coello B, Mas-Oliva J. Atherosclerosis and Cancer; A Resemblance with Far-reaching Implications. Arch Med Res 2017;48:12-26. [PMID: 28577865 DOI: 10.1016/j.arcmed.2017.03.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 9.2] [Reference Citation Analysis]
13 Stewart TA, Yapa KT, Monteith GR. Altered calcium signaling in cancer cells. Biochim Biophys Acta 2015;1848:2502-11. [PMID: 25150047 DOI: 10.1016/j.bbamem.2014.08.016] [Cited by in Crossref: 158] [Cited by in F6Publishing: 158] [Article Influence: 19.8] [Reference Citation Analysis]
14 Ma Q, Lu Y, Gu Y. ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway. Technol Cancer Res Treat 2019;18:1533033819841433. [PMID: 30947633 DOI: 10.1177/1533033819841433] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Tiapko O, Groschner K. TRPC3 as a Target of Novel Therapeutic Interventions. Cells 2018;7:E83. [PMID: 30037143 DOI: 10.3390/cells7070083] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
16 Langthaler S, Rienmüller T, Scheruebel S, Pelzmann B, Shrestha N, Zorn-Pauly K, Schreibmayer W, Koff A, Baumgartner C. A549 in-silico 1.0: A first computational model to simulate cell cycle dependent ion current modulation in the human lung adenocarcinoma. PLoS Comput Biol 2021;17:e1009091. [PMID: 34157016 DOI: 10.1371/journal.pcbi.1009091] [Reference Citation Analysis]
17 Yapa KT, Deuis J, Peters AA, Kenny PA, Roberts-thomson SJ, Vetter I, Monteith GR. Assessment of the TRPM8 inhibitor AMTB in breast cancer cells and its identification as an inhibitor of voltage gated sodium channels. Life Sciences 2018;198:128-35. [DOI: 10.1016/j.lfs.2018.02.030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
18 Curcic S, Tiapko O, Groschner K. Photopharmacology and opto-chemogenetics of TRPC channels-some therapeutic visions. Pharmacol Ther 2019;200:13-26. [PMID: 30974125 DOI: 10.1016/j.pharmthera.2019.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
19 Piyarathna DWB, Rajendiran TM, Putluri V, Vantaku V, Soni T, von Rundstedt FC, Donepudi SR, Jin F, Maity S, Ambati CR, Dong J, Gödde D, Roth S, Störkel S, Degener S, Michailidis G, Lerner SP, Pennathur S, Lotan Y, Coarfa C, Sreekumar A, Putluri N. Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder. Eur Urol Focus 2018;4:907-15. [PMID: 28753886 DOI: 10.1016/j.euf.2017.04.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
20 Moccia F, Poletto V. May the remodeling of the Ca²⁺ toolkit in endothelial progenitor cells derived from cancer patients suggest alternative targets for anti-angiogenic treatment? Biochim Biophys Acta 2015;1853:1958-73. [PMID: 25447551 DOI: 10.1016/j.bbamcr.2014.10.024] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
21 Wang T, Chen Z, Zhu Y, Pan Q, Liu Y, Qi X, Jin L, Jin J, Ma X, Hua D. Inhibition of transient receptor potential channel 5 reverses 5-Fluorouracil resistance in human colorectal cancer cells. J Biol Chem. 2015;290:448-456. [PMID: 25404731 DOI: 10.1074/jbc.m114.590364] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 6.1] [Reference Citation Analysis]
22 Wang YX, Wang L, Zheng YM. Canonical Transient Potential Receptor-3 Channels in Normal and Diseased Airway Smooth Muscle Cells. Adv Exp Med Biol 2020;1131:471-87. [PMID: 31646521 DOI: 10.1007/978-3-030-12457-1_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Wang H, Cheng X, Tian J, Xiao Y, Tian T, Xu F, Hong X, Zhu MX. TRPC channels: Structure, function, regulation and recent advances in small molecular probes. Pharmacol Ther 2020;209:107497. [PMID: 32004513 DOI: 10.1016/j.pharmthera.2020.107497] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 21.5] [Reference Citation Analysis]
24 Prevarskaya N, Skryma R, Shuba Y. Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies? Physiol Rev. 2018;98:559-621. [PMID: 29412049 DOI: 10.1152/physrev.00044.2016] [Cited by in Crossref: 134] [Cited by in F6Publishing: 129] [Article Influence: 33.5] [Reference Citation Analysis]
25 Lässig F, Klann A, Bekeschus S, Lendeckel U, Wolke C. Expression of canonical transient receptor potential channels in U-2 OS and MNNG-HOS osteosarcoma cell lines. Oncol Lett 2021;21:307. [PMID: 33732383 DOI: 10.3892/ol.2021.12568] [Reference Citation Analysis]
26 [DOI: 10.1101/518340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Girault A, Chebli J, Privé A, Trinh NT, Maillé E, Grygorczyk R, Brochiero E. Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair. Respir Res 2015;16:100. [PMID: 26335442 DOI: 10.1186/s12931-015-0263-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
28 Ke C, Long S. Dysregulated transient receptor potential channel 1 expression and its correlation with clinical features and survival profile in surgical non-small-cell lung cancer patients. J Clin Lab Anal 2022;:e24229. [PMID: 35106847 DOI: 10.1002/jcla.24229] [Reference Citation Analysis]
29 Elzamzamy OM, Johnson BE, Chen WC, Hu G, Penner R, Hazlehurst LA. Transient Receptor Potential C 1/4/5 Is a Determinant of MTI-101 Induced Calcium Influx and Cell Death in Multiple Myeloma. Cells 2021;10:1490. [PMID: 34199280 DOI: 10.3390/cells10061490] [Reference Citation Analysis]
30 Gao YY, Tian W, Zhang HN, Sun Y, Meng JR, Cao W, Li XQ. Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials. Arch Pharm Res 2021;44:354-77. [PMID: 33763843 DOI: 10.1007/s12272-021-01319-5] [Reference Citation Analysis]
31 Anand P, Filipenko P, Huaman J, Lyudmer M, Hossain M, Santamaria C, Huang K, Ogunwobi OO, Holford M. Selective Inhibition of Liver Cancer Cells Using Venom Peptide. Mar Drugs 2019;17:E587. [PMID: 31627357 DOI: 10.3390/md17100587] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
32 Gautier M, Dhennin-Duthille I, Ay AS, Rybarczyk P, Korichneva I, Ouadid-Ahidouch H. New insights into pharmacological tools to TR(i)P cancer up. Br J Pharmacol 2014;171:2582-92. [PMID: 24345078 DOI: 10.1111/bph.12561] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
33 Zhan C, Shi Y. TRPC Channels and Cell Proliferation. Adv Exp Med Biol 2017;976:149-55. [PMID: 28508320 DOI: 10.1007/978-94-024-1088-4_13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
34 Gaunt HJ, Vasudev NS, Beech DJ. Transient receptor potential canonical 4 and 5 proteins as targets in cancer therapeutics. Eur Biophys J 2016;45:611-20. [PMID: 27289383 DOI: 10.1007/s00249-016-1142-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
35 Dragoni S, Laforenza U, Bonetti E, Reforgiato M, Poletto V, Lodola F, Bottino C, Guido D, Rappa A, Pareek S, Tomasello M, Guarrera MR, Cinelli MP, Aronica A, Guerra G, Barosi G, Tanzi F, Rosti V, Moccia F. Enhanced expression of Stim, Orai, and TRPC transcripts and proteins in endothelial progenitor cells isolated from patients with primary myelofibrosis. PLoS One 2014;9:e91099. [PMID: 24603752 DOI: 10.1371/journal.pone.0091099] [Cited by in Crossref: 42] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
36 Zhang Z, Wang J, He J, Zeng X, Chen X, Xiong M, Zhou Q, Guo M, Li D, Lu W. Identification of TRPCs genetic variants that modify risk for lung cancer based on the pathway and two-stage study. Meta Gene 2016;9:191-6. [PMID: 27617218 DOI: 10.1016/j.mgene.2016.07.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
37 Rodrigues T, Sieglitz F, Bernardes GJ. Natural product modulators of transient receptor potential (TRP) channels as potential anti-cancer agents. Chem Soc Rev 2016;45:6130-7. [PMID: 26890476 DOI: 10.1039/c5cs00916b] [Cited by in Crossref: 44] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
38 Déliot N, Constantin B. Plasma membrane calcium channels in cancer: Alterations and consequences for cell proliferation and migration. Biochimica et Biophysica Acta (BBA) - Biomembranes 2015;1848:2512-22. [DOI: 10.1016/j.bbamem.2015.06.009] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 13.6] [Reference Citation Analysis]
39 Santoni G, Maggi F, Morelli MB, Santoni M, Marinelli O. Transient Receptor Potential Cation Channels in Cancer Therapy. Med Sci (Basel) 2019;7:E108. [PMID: 31801263 DOI: 10.3390/medsci7120108] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
40 Van den Eynde C, De Clercq K, Van Bree R, Luyten K, Annibali D, Amant F, Han S, Van Nieuwenhuysen E, Baert T, Peeraer K, Voets T, Van Gorp T, Vriens J. TRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma. Cell Mol Life Sci 2021. [PMID: 34936030 DOI: 10.1007/s00018-021-04023-1] [Reference Citation Analysis]
41 Wang Y, Qi YX, Qi Z, Tsang SY. TRPC3 Regulates the Proliferation and Apoptosis Resistance of Triple Negative Breast Cancer Cells through the TRPC3/RASA4/MAPK Pathway. Cancers (Basel) 2019;11:E558. [PMID: 31003514 DOI: 10.3390/cancers11040558] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
42 Yang LL, Liu BC, Lu XY, Yan Y, Zhai YJ, Bao Q, Doetsch PW, Deng X, Thai TL, Alli AA, Eaton DC, Shen BZ, Ma HP. Inhibition of TRPC6 reduces non-small cell lung cancer cell proliferation and invasion. Oncotarget 2017;8:5123-34. [PMID: 28030826 DOI: 10.18632/oncotarget.14034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
43 Shapovalov G, Gordienko D, Prevarskaya N. Store operated calcium channels in cancer progression. Int Rev Cell Mol Biol 2021;363:123-68. [PMID: 34392928 DOI: 10.1016/bs.ircmb.2021.02.016] [Reference Citation Analysis]
44 Shilpi A, Bi Y, Jung S, Patra SK, Davuluri RV. Identification of Genetic and Epigenetic Variants Associated with Breast Cancer Prognosis by Integrative Bioinformatics Analysis. Cancer Inform 2017;16:1-13. [PMID: 28096648 DOI: 10.4137/CIN.S39783] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
45 Duranti C, Arcangeli A. Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis. Antibodies (Basel) 2019;8:E33. [PMID: 31544839 DOI: 10.3390/antib8020033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
46 Sharma A, Ramena GT, Elble RC. Advances in Intracellular Calcium Signaling Reveal Untapped Targets for Cancer Therapy. Biomedicines 2021;9:1077. [PMID: 34572262 DOI: 10.3390/biomedicines9091077] [Reference Citation Analysis]
47 Guéguinou M, Gambade A, Félix R, Chantôme A, Fourbon Y, Bougnoux P, Weber G, Potier-Cartereau M, Vandier C. Lipid rafts, KCa/ClCa/Ca2+ channel complexes and EGFR signaling: Novel targets to reduce tumor development by lipids? Biochim Biophys Acta 2015;1848:2603-20. [PMID: 25450343 DOI: 10.1016/j.bbamem.2014.10.036] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]